Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
journalStr:"Breast cancer research and treatment"
topic_facet:"EC 2.7.10.1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Breast+cancer+research+and+treatment%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (41)
1
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy
enthalten in:
Breast cancer research and treatment
| 2023
von
Iwata, H.
|
Yamamoto, Y.
|
Sakai, T.
| +12
Wird geladen...
2
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN) : final analysis of a phase III, randomized, double-blind, placebo-controlled study
enthalten in:
Breast cancer research and treatment
| 2023
von
Xu, B.
|
Li, W.
|
Zhang, Q.
| +11
Wird geladen...
3
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer : subgroup analysis of the phase IIIb CompLEEment-1 trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Campone, M.
|
De Laurentiis, M.
|
Zamagni, C.
| +8
Wird geladen...
4
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer : primary results from cohort B of the IPATunity130 randomized phase 3 trial
enthalten in:
Breast cancer research and treatment
| 2022
von
Turner, N.
|
Dent, R.
|
O'Shaughnessy, J.
| +13
Wird geladen...
5
Analysis of the pan-Asian subgroup of patients in the NALA Trial : a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
enthalten in:
Breast cancer research and treatment
| 2021
von
Dai, M.
|
Feng, Y.
|
Chen, S.
| +23
Wird geladen...
6
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
enthalten in:
Breast cancer research and treatment
| 2021
von
De Laurentiis, M.
|
Borstnar, S.
|
Campone, M.
| +15
ErratumIn: Breast Cancer Res Treat. 2021 Oct 8;:. - PMID 34625861
Wird geladen...
7
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer : final results from a randomized phase III trial
enthalten in:
Breast cancer research and treatment
| 2021
von
Stebbing, J.
|
Baranau, Y.
|
Baryash, V.
| +11
Wird geladen...
8
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer : Final analysis of MetaPHER, a phase IIIb single-arm safety study
enthalten in:
Breast cancer research and treatment
| 2021
von
Kuemmel, S.
|
Tondini, C.
|
Abraham, J.
| +13
Wird geladen...
9
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
enthalten in:
Breast cancer research and treatment
| 2021
von
Huang, C.
|
Yang, Y.
|
Kwong, A.
| +10
Wird geladen...
10
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer : an age-specific subgroup analysis of MONARCH 2 and 3 trials
enthalten in:
Breast cancer research and treatment
| 2021
von
Goetz, M.
|
Okera, M.
|
Wildiers, H.
| +8
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Zeitschrift: Breast cancer research and treatment
Filter aufheben
Thema: EC 2.7.10.1
Medienart
41
Aufsätze
41
E-Artikel
E-Ressourcen
Zeitschriftentitel
Breast cancer research and treatment
Thema
41
Clinical Trial, Phase III
EC 2.7.10.1
41
Journal Article
40
Receptor, ErbB-2
30
Randomized Controlled Trial
23
ERBB2 protein, human
16
Receptors, Estrogen
15
Multicenter Study
15
P188ANX8CK
15
Trastuzumab
13
Research Support, Non-U.S. Gov't
12
Receptors, Progesterone
11
Breast cancer
10
Biomarkers, Tumor
8
15H5577CQD
8
7LKK855W8I
8
Docetaxel
8
Letrozole
7
Antibodies, Monoclonal, Humanized
7
Taxoids
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
16
2020-
23
2010-2019
2
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
41
Englisch
Haven't found what you're looking for?
Wird geladen...